Caption Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-675,000
Closed -$16.8M 1936
2025
Q4
$16.8M Buy
675,000
+237,500
+54% +$5.99M 0.12% 213
2025
Q3
$11.1M Buy
+437,500
New +$10.8M 0.09% 253
2025
Q2
Sell
-350,000
Closed -$8.87M 1796
2025
Q1
$8.87M Buy
+350,000
New +$9.16M 0.09% 231
2023
Q2
Sell
-300,000
Closed -$12.2M 1330
2023
Q1
$12.2M Buy
+300,000
New +$13M 0.24% 99
2022
Q3
Sell
-150,000
Closed -$7.86M 1766
2022
Q2
$7.86M Sell
150,000
-50,000
-25% -$2.55M 0.11% 241
2022
Q1
$10.4M Buy
+200,000
New +$10.4M 0.12% 207
2020
Q4
Sell
-737,800
Closed -$25.7M 1192
2020
Q3
$25.7M Buy
+737,800
New +$25.9M 0.6% 21
2020
Q1
Sell
-42,160
Closed -$1.57M 1021
2019
Q4
$1.57M Hold
42,160
0.05% 403
2019
Q3
$1.44M Buy
+42,160
New +$1.53M 0.07% 310

Other funds holding PFE

Caption Management's PFE Position: Q1 2026 in Review

Caption Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 134,800 shares — an estimated $3.59M sold.

Caption Management first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $13.7M in Q3 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caption Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 134,800 Pfizer shares in Q1 2026, an estimated $3.59M.
  • Caption Management first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
  • Caption Management's Pfizer position peaked at $13.7M in Q3 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.